PharmaTimes: News RSS
- Boehringer Ingelheim and Enara Bio join forces to discover cancer immunotherapies
- Verona completes enrolment in pilot study of potential COVID-19 inhaler
- US breakthrough designation for ligelizumab in chronic spontaneous urticaria
- NICE backs GSK’s Zejula in advanced ovarian cancer
- NHS England selects supermarket Asda to operate COVID-19 vaccination centre
- EU approval for ViiV’s Tivicay for children living with HIV
- Valneva partners with Oxford Immunotec on T cell analysis for COVID-19 vaccine
- Gilead and Vir unite to find a ‘functional cure’ for hepatitis B
- Roche’s Tecentriq/Avastin combo improves survival in liver cancer
- Diurnal seeks marketing authorisation for Chronocort in the UK
English
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish
Leave a Reply
Want to join the discussion?Feel free to contribute!